Navigating Adjuvant Therapy in ER-Positive Breast Cancer

This chapter explores recent clinical trial results, specifically the Monarch E and NATALI trials, regarding adjuvant therapy for ER-positive breast cancer. The discussion centers on treatment implications, dosing strategies, patient comorbidities, and the complexities of care in light of new information.